Tatva Chintan Pharma IPO

IPO Status: Closed [16th Jul 2021 to 20th Jul 2021]

Rated 4/5 by Team TopShareBrokers

Tatva Chintan Pharma, a chemical manufacturing company in India is coming up with an IPO of Rs. 500 Cr. The IPO opens for subscription on 16 July and closes on 20 July. The price band is fixed at Rs. 1073-1083, the floor price is 107.3 times and the cap price is 108.3 times of Rs. 10 face value. One can apply for the lot size of 13 shares and it's multiple. Stay updated to know more about Tatva Chintan Pharma IPO including business overview, financial performance, recommendations, live subscription, allotment, GMP, and more.

Tatva Chintan Pharma IPO Details

IPO Issue Opening Date:	16th Jul 2021
IPO Issue Closing Date:	20th Jul 2021
IPO Issue Price:	₹1073-1083 Per Share
DRHP:	View DRHP
RHP:	View RHP
IPO Listing At:	BSE, NSE
Retail Quota:	50%
IPO Issue Type:	Book Build Issue
IPO Issue Size:	₹500 Cr
Offer for Sale:	₹275 Cr
Fresh Issue:	₹225 Cr
Face Value:	₹10 Per Equity Share
IPO Discount:	NA
Promoter Holding Pre IPO:	100%
Promoter Holding Post IPO:	79.17%
Allotment Status:	Allotment Status
BSE Code:	543321
NSE Code:	TATVA

IPO Live GMP

Tatva Chintan Pharma IPO Important Dates

In this section we have covered all important dates related to Tatva Chintan Pharma IPO. Dates are updated as they are announced. The most noted dates are IPO start date and IPO end date, which one should use to participate in IPO.

Tatva Chintan Pharma IPO important dates
IPO Activity	Date
IPO Issue Open	16th Jul 2021
IPO Issue Close	20th Jul 2021
Basis of Allotment Date*	26th Jul 2021
Refunds Initiation*	27th Jul 2021
Credit of Shares to Demat*	28th Jul 2021
IPO Listing Date*	29th Jul 2021

* - Tentative Dates

Tatva Chintan Pharma IPO Lots

IPO Activity	Date
Issue Price	₹1073-1083
Market Lot:	13 Shares
1 Lot Amount:	₹14079
Max Retail Lots:	182 shares(14 lots)
Min HNI Lots:	195 shares(15 lots)

Save 60% to 90% Brokerage

Start your investment journey with India's number one discount broker - Zerodha. Free delivery trade and free mutual funds Investment. Flat Rs 20 for Intraday,F&O, Currency and Commodity Trade.
Open Account Now

About Company - Tatva Chintan Pharma

Tatva Chintan Pharma Chem Limited is one of the leading Indian manufacturers of Structure Directing Agents (SDAs) for zeolites. The company manufactures structure-directing agents, phase transfer catalysts, pharmaceutical, and agrochemical ingredients, and other specialty chemicals to meet diverse requirements of various industries i.e. automotive, agrochemicals, petroleum, paints and coatings, dyes and pigments, pharmaceutical, personal care, and others. Merck, Bayer AG, SRF Ltd, Navin Fluorine International Ltd, Atul Ltd, Divi's Laboratories, etc. are some of its prominent customers. The company sells its products in India and overseas markets such as the USA, UK, China, Germany, and South Africa.

Tatva Chintan Pharma IPO Strengths

One of the leading manufacture of structure directing agents and phase transfer catalyst.
Intenational market presence with export to 25+ countries.
Manufacturing facility in Gujarat with close proximity to Hazira port.
Consistent track record of financial performance.
Highly experienced team of promoters and managers.

Incorporation	Sector	IPO Issue Size	Website
1996	Specialty Chemical	₹500 Cr	http://www.tatvachintan.com/

Tatva Chintan Pharma IPO Objective

To finance the capital expenditure requirements of expansion of Dahej manufacturing facility.
To finance the capital expenditure requirements to upgrade R&D facilities in Vadodara.
Meeting capital expenditures requirements.

Tatva Chintan Pharma IPO Live Subscription (NSE + BSE)

The table below is live update of IPO bidding details from NSE and BSE.

Qualified Institutional Buyers: 931,966 Shares
Non-Institutional Investors: 698,975 Shares
Retail Individual Investor: 1,630,941 Shares

IPO Bidding Live Updates from BSE + NSE
Day		QIB	NII	RII	Total
	# of Shares Offered	931,966 (28.57%)	698,975 (21.43%)	1,630,941 (50%)	3,261,882
1	16th Jul 2021 17:03	0.50x	1.14x	8.24x	4.51x
2	19th Jul 2021 17:02	1.97x	12.21x	23.74x	15.05x
3	20th Jul 2021 17:03	185.23x	512.22x	35.35x	180.36x

Tatva Chintan Pharma Financials for past 3 Years

Past performance and financial results of Tatva Chintan Pharma.

Tatva Chintan Pharma financial
Tatva Chintan Pharma Chem Financials	31-Mar-2021	31-Mar-2020	31-Mar-2019	31-Mar-2018
Total Assets	₹314.80 Cr	₹248.94 Cr	₹187.51 Cr	₹143.72 Cr
Total Income	₹306.29 Cr	₹264.62 Cr	₹206.80 Cr	₹137.29 Cr
Net Profit/Loss	₹52.26 Cr	₹37.79 Cr	₹20.54 Cr	₹12.29 Cr

Company Address

Tatva Chintan Pharma Chem Limited
Plot No. 502 / 17, GIDC Estate, Ankleshwar,
Bharuch,Gujarat-393002
India
Website: http://www.tatvachintan.com/
Phone: +91 75730 46951
Email: [email protected]

Tatva Chintan Pharma IPO Registrar

Link Intime India Private Ltd
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Website: http://www.linkintime.co.in
Phone: +91-22-4918 6270
Email: [email protected]kintime.co.in

Tatva Chintan Pharma IPO Lead Manager

ICICI Securities Limited
JM Financial Consultants Private Limited

Tatva Chintan Pharma IPO Important dates - Issue Open Date, close Date, IPO Listing Date. IPO Details - Offer Size, Issue Size, Type of IPO, Issue Price, Market Lot, BSE Cd, NSE Cd, IPO Listing date. What is the issue open date and close date for Tatva Chintan Pharma? Should I apply in Tatva Chintan Pharma IPO?

Last Updated on 2021-09-27T10:40:21+00:00

User Reviews

5. Jagadeesh Jul 12 2021 01:57:39 AM Reply

Tatva Chintan Pharma IPO expected listing gain.

4. ganesh Jul 12 2021 01:57:39 AM Reply

Please confirm Tatva Chintan Pharma IPO GMP (grey market premium) and kostak.

3. Shoaib Jul 12 2021 01:57:39 AM Reply

Tatva Chintan Pharma IPO good or bad.

2. Leela Jul 12 2021 01:57:39 AM Reply

Tatva Chintan Pharma IPO whether to invest or not.

1. Vinutha V Jul 12 2021 01:57:39 AM Reply

Tatva Chintan Pharma IPO - CRISIL Rating, Apply or not?.